Boston Scientific Corp (BSX)

Receivables turnover

		Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020	Dec 31, 2019	Sep 30, 2019	Jun 30, 2019	Mar 31, 2019
Revenue (ttm)	US$ in thousands	13,974,000	10,508,000	10,348,000	9,999,000	9,228,000	12,104,000	11,689,000	11,502,000	11,625,000	11,168,000	10,855,000	9,774,000	9,553,000	9,751,000	9,790,000	10,420,000	10,349,000	10,035,000	9,758,000	9,649,000
Receivables	US$ in thousands	2,228,000	2,101,000	2,134,000	2,076,000	1,970,000	1,871,000	1,917,000	1,866,000	1,778,000	1,669,000	1,675,000	1,631,000	1,531,000	1,598,000	1,457,000	1,702,000	1,933,000	1,796,000	1,712,000	1,621,000
Receivables turnover		6.27	5.00	4.85	4.82	4.68	6.47	6.10	6.16	6.54	6.69	6.48	5.99	6.24	6.10	6.72	6.12	5.35	5.59	5.70	5.95

December 31, 2023 calculation

Receivables turnover = Revenue (ttm) ÷ Receivables
= $13,974,000K ÷ $2,228,000K
= 6.27

The receivables turnover ratio for Boston Scientific Corp. has been relatively stable over the past eight quarters, ranging from 6.28 to 6.72. This ratio indicates how efficiently the company is collecting cash from its credit sales within a specific period. A higher receivables turnover ratio is generally preferable as it suggests that the company is able to collect its accounts receivable more quickly.

Although there was some fluctuation in the ratio quarter over quarter, the overall trend has been consistent, hovering around the mid-six range. This could indicate that Boston Scientific Corp. has effective credit and collection policies in place to manage its accounts receivable efficiently.

It is important for the company to monitor its receivables turnover ratio regularly to ensure that it remains stable and in line with industry benchmarks. Any significant deviations from the norm may warrant further investigation into the company's credit management practices and customer payment behaviors.